Loading...

Jonathan Hsu

TitleAssociate Clinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9300 Campus Point Drive #7411
La Jolla CA 92037
Phone858-246-2972
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoMAS (Masters in Advanced Studies, Clinical Research)
    University of California, San FranciscoClinical Cardiac Electrophysiology Fellowship
    University of California, San FranciscoCardiovascular Medicine Fellowship
    Massachusetts General HospitalInternal Medicine Residency
    Northwestern UniversityMD
    Northwestern UniversityBA

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Aldaas OM, Padwal J, Hsu J. Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction. J Am Coll Cardiol. 2018 Mar 20; 71(11):1292-1293. PMID: 29544616.
      View in: PubMed
    2. Hoffmayer KS, Krainski F, Shah S, Hunter J, Alegre M, Hsu J, Feld GK. Randomized controlled trial of Amigo® robotically controlled versus manually controlled ablation of the cavo-tricuspid isthmus using a contact force ablation catheter. J Interv Card Electrophysiol. 2018 Mar; 51(2):125-132. PMID: 29435790.
      View in: PubMed
    3. Hsu J, Freeman JV. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review. Clin Pharmacol Ther. 2018 Jan 12. PMID: 29328506.
      View in: PubMed
    4. Kusumoto FM, Hao SC, Slotwiner DJ, Cheung JW, Hsu J, Kowalski M, Madden RA, Mason PK, Mendenhall GS, Nair DG, Nasir JM, Silverstein JR, Sutton B, Tarakji KG, Upadhyay GA, Zeitler EP. Arrhythmia care in a value-based environment: Past, present, and future: Developed and endorsed by the Heart Rhythm Society (HRS). Heart Rhythm. 2018 Feb; 15(2):e5-e15. PMID: 29254674.
      View in: PubMed
    5. Nishimura M, Sab S, Reeves RR, Hsu J. Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review. Europace. 2017 Dec 08. PMID: 29228158.
      View in: PubMed
    6. Nishimura M, Thomas I, Hsu J. Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When Is the Most Clinically Relevant Time to Evaluate? JAMA Cardiol. 2017 Dec 01; 2(12):1397. PMID: 28973138.
      View in: PubMed
    7. Nishimura M, Hsu J. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease. Am J Cardiol. 2018 Jan 01; 121(1):131-140. PMID: 29132650.
      View in: PubMed
    8. Hsu J, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry). Am J Cardiol. 2018 Jan 01; 121(1):55-61. PMID: 29102348.
      View in: PubMed
    9. Kipp R, Hsu J, Freeman J, Curtis J, Bao H, Hoffmayer KS. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry. Heart Rhythm. 2017 Oct 05. PMID: 28987459.
      View in: PubMed
    10. Yong CM, Liu Y, Apruzzese P, Doros G, Cannon CP, Maddox TM, Gehi A, Hsu J, Lubitz SA, Virani S, Turakhia MP. Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry. Am Heart J. 2018 Jan; 195:50-59. PMID: 29224646.
      View in: PubMed
    11. Nishimura M, Sab S, Birgersdotter-Green U, Krummen D, Schricker A, Raissi F, Hoffmayer KS, Feld GK, Hsu J. Reasons for and predictors of acute hospitalization versus elective outpatient implantable cardioverter-defibrillator implantation and subsequent differential clinical outcomes. J Interv Card Electrophysiol. 2017 Oct; 50(1):85-93. PMID: 28844089.
      View in: PubMed
    12. Chang KW, Hsu J, Toomu A, Fox S, Maisel AS. Clinical Applications of Biomarkers in Atrial Fibrillation. Am J Med. 2017 Dec; 130(12):1351-1357. PMID: 28822701.
      View in: PubMed
    13. Chang KW, Arbit B, Hsu J. Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review. Int J Cardiol. 2017 Sep 15; 243:263-269. PMID: 28595745.
      View in: PubMed
    14. Marzec LN, Wang J, Shah ND, Chan PS, Ting HH, Gosch KL, Hsu J, Maddox TM. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2017 May 23; 69(20):2475-2484. PMID: 28521884.
      View in: PubMed
    15. Katz DF, Maddox TM, Turakhia M, Gehi A, O'Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu J. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry. Circ Cardiovasc Qual Outcomes. 2017 May; 10(5). PMID: 28506981.
      View in: PubMed
    16. Hsu J, Hoffmayer KS. The Relationship of Antitachycardia Pacing versus Shock in an Implantable Cardioverter-Defibrillator Population and the Risk of Mortality: Just an Association? J Cardiovasc Electrophysiol. 2017 Apr; 28(4):423-424. PMID: 28176398.
      View in: PubMed
    17. Kipp RT, Abu Sham'a R, Hiroyuki I, Han FT, Refaat M, Hsu J, Field ME, Kopp DE, Marcus GM, Scheinman MM, Hoffmayer KS. Concealed Accessory Pathways with a Single Ventricular and Two Discrete Atrial Insertion Sites. Pacing Clin Electrophysiol. 2017 Mar; 40(3):255-263. PMID: 28098354.
      View in: PubMed
    18. Khan F, Feld GK, Schricker A, Han FT, Hoffmayer KS, Hsu J. A surgeon with symptomatic ventricular tachycardia while operating and exacerbated by left lateral decubitus position: Too much of a stretch? HeartRhythm Case Rep. 2017 Apr; 3(4):210-214. PMID: 28491804.
      View in: PubMed
    19. Gehi AK, Doros G, Glorioso TJ, Grunwald GK, Hsu J, Song Y, Turakhia MP, Turchin A, Virani SS, Maddox TM. Factors associated with rhythm control treatment decisions in patients with atrial fibrillation-Insights from the NCDR PINNACLE registry. Am Heart J. 2017 May; 187:88-97. PMID: 28454812.
      View in: PubMed
    20. Nishimura M, Hsu J. A Cautionary Tone Before Expanded Adoption of the Proposed CHA2DS2-VASc R Score. J Am Coll Cardiol. 2017 Jan 17; 69(2):251. PMID: 28081839.
      View in: PubMed
    21. Hsu J, Maddox TM, Marcus GM. Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed. J Am Coll Cardiol. 2016 Dec 06; 68(22):2493. PMID: 27908359.
      View in: PubMed
    22. Hsu J, Akao M, Abe M, Anderson KL, Avezum A, Glusenkamp N, Kohsaka S, Lane DA, Lip GY, Ma CS, Masoudi FA, Potpara TS, Siong TW, Turakhia MP, Tse HF, Rumsfeld JS, Maddox TM. International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. J Am Heart Assoc. 2016 Nov 02; 5(11). PMID: 27806965.
      View in: PubMed
    23. Salcedo JD, Pretorius VG, Hsu J, Lalani GG, Schricker AA, Hebsur SM, McGARRY TJ, Hunter JA, Lewis KE, Krummen DE, Feld GK, Birgersdotter-Green U. Compatibility of Radiofrequency Surgical Sponge Detection Technology with Cardiac Implantable Electronic Devices and Temporary Pacemakers. Pacing Clin Electrophysiol. 2016 Nov; 39(11):1254-1260. PMID: 27550834.
      View in: PubMed
    24. Hsu J, Maddox TM, Marcus GM. Overtreatment of Low-Risk Patients With Atrial Fibrillation-The Quality Coin Has 2 Sides-Reply. JAMA Cardiol. 2016 Oct 01; 1(7):849. PMID: 27541439.
      View in: PubMed
    25. Hsu J. Cardiac Tamponade From Permanent Pacemaker Implantation: Is the Pressure Building? JACC Clin Electrophysiol. 2017 Jan; 3(1):47-49. PMID: 29759694.
      View in: PubMed
    26. Lalani GG, Schricker AA, Salcedo J, Hebsur S, Hsu J, Feld G, Birgersdotter-Green U. Cardiac Device Implant Skin Closure with a Novel Adjustable, Coaptive Tape-Based Device. Pacing Clin Electrophysiol. 2016 Oct; 39(10):1077-1082. PMID: 27470060.
      View in: PubMed
    27. Katz DF, Peterson P, Borne RT, Betz J, Al-Khatib SM, Varosy PD, Wang Y, Hsu J, Hoffmayer KS, Kipp RT, Hansen CM, Turakhia MP, Masoudi FA. Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry. JACC Clin Electrophysiol. 2017 Jan; 3(1):20-28. PMID: 29759690.
      View in: PubMed
    28. Arbit B, Nishimura M, Hsu J. Reversal agents for direct oral anticoagulants: A focused review. Int J Cardiol. 2016 Nov 15; 223:244-250. PMID: 27541665.
      View in: PubMed
    29. Hsu J, Maddox TM, Kennedy K, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke. J Am Coll Cardiol. 2016 Jun 28; 67(25):2913-23. PMID: 27339487.
      View in: PubMed
    30. Schricker AA, Krummen DE, Hsu J. Atrial Fibrillation: Beyond the Pulmonary Veins. J Am Coll Cardiol. 2016 Jun 07; 67(22):2700-1. PMID: 27256840.
      View in: PubMed
    31. Kawata H, Hirai T, Doukas D, Hirai R, Steinbrunner J, Wilson J, Noda T, Hsu J, Krummen D, Feld G, Wilber D, Santucci P, Birgersdotter-Green U. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications. J Cardiovasc Electrophysiol. 2016 06; 27(6):724-9. PMID: 26915696.
      View in: PubMed
    32. Daniels LB, Lee NS, Hsu J. Natriuretic Peptides for Predicting Left Atrial Reverse Remodeling After Atrial Fibrillation Ablation: Too Much of a Stretch? JACC Clin Electrophysiol. 2016 Apr; 2(2):159-161. PMID: 29766865.
      View in: PubMed
    33. Hsu J, Maddox TM, Kennedy KF, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry. JAMA Cardiol. 2016 04 01; 1(1):55-62. PMID: 27437655.
      View in: PubMed
    34. Greenberg JA, Hsu J, Bawazeer M, Marshall J, Friedrich JO, Nathens A, Coburn N, May GR, Pearsall E, McLeod RS. Clinical practice guideline: management of acute pancreatitis. Can J Surg. 2016 Apr; 59(2):128-40. PMID: 27007094; PMCID: PMC4814287.
    35. Arbit B, Padwal J, Hsu J. Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2016 01 07; 374(1):92. PMID: 26736008.
      View in: PubMed
    36. Al-Khatib SM, Arshad A, Balk EM, Das SR, Hsu J, Joglar JA, Page RL. Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2016 Apr; 13(4):e222-37. PMID: 26409096.
      View in: PubMed
    37. Al-Khatib SM, Arshad A, Balk EM, Das SR, Hsu J, Joglar JA, Page RL. Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 05; 67(13):1624-1638. PMID: 26409260.
      View in: PubMed
    38. Al-Khatib SM, Arshad A, Balk EM, Das SR, Hsu J, Joglar JA, Page RL. Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 05; 133(14):e575-86. PMID: 26399661.
      View in: PubMed
    39. Arbit B, Hsu J. Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review. Clin Cardiol. 2015 Nov; 38(11):684-91. PMID: 26173428.
      View in: PubMed
    40. Hsu J, Chan PS, Tang F, Maddox TM, Marcus GM. Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry. JAMA Intern Med. 2015 Jun; 175(6):1062-5. PMID: 25867280; PMCID: PMC4540345.
    41. Hsu J, Saxon LA, Jones PW, Wehrenberg S, Marcus GM. Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study. Heart Rhythm. 2015 Aug; 12(8):1770-5. PMID: 25916569.
      View in: PubMed
    42. Kawamura M, Hsu J, Vedantham V, Marcus GM, Hsia HH, Gerstenfeld EP, Scheinman MM, Badhwar N. Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: Comparison of apical crux area and posterior septal left ventricle. Heart Rhythm. 2015 Jun; 12(6):1137-44. PMID: 25728755.
      View in: PubMed
    43. Hsu J, Chan PS, Tang F, Maddox TM, Marcus GM. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation. Am J Med. 2015 Jun; 128(6):654.e1-654.e10. PMID: 25554371; PMCID: PMC4540340.
    44. Hsu J, Varosy PD, Parzynski CS, Chaudhry SI, Dewland TA, Curtis JP, Marcus GM. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry. Am Heart J. 2015 Jan; 169(1):45-52.e3. PMID: 25497247.
      View in: PubMed
    45. Hsu J, Marcus GM, Al-Khatib SM, Wang Y, Curtis JP, Sood N, Parker MW, Kluger J, Lampert R, Russo AM. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2014 Jul 22; 64(3):256-64. PMID: 25034061.
      View in: PubMed
    46. Hoffmayer KS, Dewland TA, Hsia HH, Badhwar N, Hsu J, Tseng ZH, Marcus GM, Scheinman MM, Gerstenfeld EP. Safety of radiofrequency catheter ablation without coronary angiography in aortic cusp ventricular arrhythmias. Heart Rhythm. 2014 Jul; 11(7):1117-21. PMID: 24732373.
      View in: PubMed
    47. Roberts JD, Hsu J, Aouizerat BE, Pullinger CR, Malloy MJ, Kane JP, Olgin JE, Marcus GM. Impact of a 4q25 genetic variant in atrial flutter and on the risk of atrial fibrillation after cavotricuspid isthmus ablation. J Cardiovasc Electrophysiol. 2014 Mar; 25(3):271-277. PMID: 24237655; PMCID: PMC3947706.
    48. Feld GK, Tate C, Hsu J. Esophageal temperature monitoring during AF ablation: multi-sensor or single-sensor probe? J Cardiovasc Electrophysiol. 2013 Dec; 24(12):E24. PMID: 24118278.
      View in: PubMed
    49. Hsu J, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Sep 17; 2(5):e000428. PMID: 24045120; PMCID: PMC3835257.
    50. Soleimani Rahbar A, Hsu J, Han FT, Nguyen N, Kwon M, Azadani PN, Marcus GM, Lee BK. Trainee inexperience is associated with longer procedure times but no increase in complications for cardiac device implantation. Heart Rhythm. 2013 Dec; 10(12):1755-8. PMID: 24016696.
      View in: PubMed
    51. Hsu J, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):582-90. PMID: 24002030.
      View in: PubMed
    52. Dewland TA, Hsu J, Castellanos JM, Smith LM, Marcus GM. Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral. Am Heart J. 2013 Jul; 166(1):164-70. PMID: 23816036.
      View in: PubMed
    53. Hsu J, Li Y, Marcus GM, Hsue PY, Scherzer R, Grunfeld C, Shlipak MG. Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. J Am Coll Cardiol. 2013 Jun 04; 61(22):2288-95. PMID: 23563125.
      View in: PubMed
    54. Hsu J, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus GM. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry. J Am Heart Assoc. 2012 Dec; 1(6):e003863. PMID: 23316325; PMCID: PMC3540679.
    55. Marcus GM, Hsu J. Colchicine after pulmonary vein isolation to prevent the early recurrence of atrial fibrillation: mollifying an inflammatory response? J Am Coll Cardiol. 2012 Oct 30; 60(18):1797-8. PMID: 23040565.
      View in: PubMed
    56. Malik A, Hsu J, Hoopes C, Itinarelli G, Marcus GM. Elevated pulmonary artery systolic pressures are associated with a lower risk of atrial fibrillation following lung transplantation. J Electrocardiol. 2013 Jan-Feb; 46(1):38-42. PMID: 22999321; PMCID: PMC3690322.
    57. Hsu J, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol. 2012 Jun 19; 59(25):2366-73. PMID: 22698490.
      View in: PubMed
    58. Hsu J, Badhwar N, Lee BK, Vedantham V, Tseng ZH, Marcus GM. Predictors of fluoroscopy time and procedural failure during biventricular device implantation. Am J Cardiol. 2012 Jul 15; 110(2):240-5. PMID: 22483384; PMCID: PMC3383869.
    59. Hsu J, Friday J, Lee BK, Azadani PN, Lee RJ, Badhwar N, Tseng ZH, Olgin JE, Marcus GM. Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol. 2011 Dec; 34(12):1585-92. PMID: 21819433.
      View in: PubMed
    60. Hoffmayer KS, Yang Y, Joseph S, McCabe JM, Bhave P, Hsu J, Ng RK, Lee BK, Badhwar N, Lee RJ, Tseng ZH, Olgin JE, Narayan SM, Marcus GM, Scheinman MM. Predictors of unusual ECG characteristics in cavotricuspid isthmus-dependent atrial flutter ablation. Pacing Clin Electrophysiol. 2011 Oct; 34(10):1251-7. PMID: 21605144; PMCID: PMC3395429.
    61. Hsu J, Goldschlager N. An Unusual Case of Pacemaker Malfunction. Card Electrophysiol Clin. 2010 Jun; 2(2):285-288. PMID: 28770765.
      View in: PubMed
    62. Hsu J, Tanel RE, Lee BK, Scheinman MM, Badhwar N, Lee RJ, Tseng ZH, Olgin JE, Marcus GM. Differences in accessory pathway location by sex and race. Heart Rhythm. 2010 Jan; 7(1):52-6. PMID: 19914144; PMCID: PMC2818171.
    63. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm. 2006 Oct; 3(10):1196-201. PMID: 17018351.
      View in: PubMed